Synopsis
This
study aimed to compare Intravoxel Incoherent Motion (IVIM) to more established measures
of perfusion; Arterial Spin Labelling (ASL), Dynamic Contrast Enhanced (DCE)
and Dynamic Contrast Susceptibility (DSC) imaging, both in tumours and white
matter. Mean and 95th percentile values for f, D*, fD*, CBF, Ktrans,
ve, vb, rCBV and K2 were calculated. Multiple
correlations were observed. Significant correlations of note include CBF vs.
fD*, vb vs. rCBV and Ktrans vs. K2. Spatial
registration of the 4 different methods yielded acceptable agreement given technical
differences.Introduction
This study aimed to compare Intravoxel Incoherent
Motion (IVIM) to more established measures of perfusion; Arterial Spin Labelling
(ASL), Dynamic Contrast Enhanced (DCE) and Dynamic Contrast Susceptibility
(DSC) imaging, both in tumours and white matter, with the link between IVIM and
tracer kinetics proposed for over 20 years
1. This study may be
of interest to neuroradiologists
and clinical scientists.
Methods
Whole brain multiparametric
MR data sets were acquired from 11 patients with suspected malignant brain
pathologies following consent using a 3.0T system and eight channel phased
array head coil. Morphological imaging was acquired along with:
ASL (pCASL) – pulse label delay 2025ms, 10 arms, 1024 arm length, 3 NEX, 5 mm
slice thickness, 32 locations
IVIM - 15 b-values (0, 10, 20, 30, 40, 50, 60, 75, 100, 150, 200, 350, 500,
750, 1000 mm-2s), 3 directions, 128x128 matrix, 240mm FOV, 2.5mm
slice thickness, 56 slices
T1 DCE – 6s
temporal resolution, 60 phases, 192x96 matrix, 240mm FOV, 20° flip angle, 5.0mm
slice thickness overlapped to 2.5mm thick reconstructed images, 44 slices, scan
time 6.17. Pre-contrast volumes of 3, 5, 7, 10, 20 and 30° flip angles were
used to calculate tissue T1 relaxation times, ¾ dose of gadolinium
contrast agent
T2* DSC – GRE-EPI,
2s temporal resolution, 50 phases, 128x128 matrix, 240mm FOV, 5.0mm slice
thickness, 29 slices, ¾ dose of gadolinium contrast agent.
Data was processed using in-house
software, except ASL the scanner calculated. Motion correction and registration
was implemented using FSL2. IVIM parameters
were flow fraction (f), perfusion fraction (D*) and blood flow (fD*). Pharmacokinetic
modelling using a two compartment Tofts-Kety model was used to generate Ktrans,
ve and vb. DSC-MRI was processed using a contrast agent
extravasation correction model3, generating the T2*
leakage parameter K2, with the subsequently corrected cerebral blood
volume normalised to global white matter (rCBV). All parametric maps were spatially
registered prior to sampling.
Pre- and post-contrast T1
volume subtraction maps were used to contour enhancing lesions, whist T2
FLAIR hyperintensity was used for non-enhancing lesions. White matter was sampled
on a single representative slice (Figure 1). Mean and 95th
percentile measurements were obtained for both tissue groups with cross-modal
comparisons made using Pearson’s test.
Results
In the 11 patients, 6 cases
of glioblastoma multiforme (WHO IV) were diagnosed along with 1 anaplastic meningioma
(WHO III), 1 anaplastic ependymoma (WHO III), 2 diffuse astrocytomas (WHO II) and
1 case of demyelination. Mean±standard deviations in normal white matter for f,
D*, fD*, CBF, K
trans, v
e, v
b, rCBV and K
2
were: 0.08±0.01, 7.96±0.85x10
-3mm
2s
-1, 0.65±0.08x10
-3mm
2s
-1,
29.65±6.70ml100g
-1min
-1, 0.03±0.01min
-1, 0.05±0.02,
0.03±0.01, 1.34±0.10 and 0.37±0.12 respectively. Correlations between perfusion
measures are shown for mean (Figure 2) and 95
th percentile values
(Figure 3). Correlation coefficients and p-values for both figures are shown in
Figure 4.
Discussion
To the author’s knowledge,
this is the first brain study to acquire all 4 techniques in a single examination.
IVIM values for white matter were comparable to Wu
et al.4
with f and D* reported as 0.07±0.01 and 7.9±0.9x10
-3mm
2s
-1.
Bisdas
et al.5
also reported similar white matter values for f, D*, fD*, 0.07±0.02, 5.35±2.29x10
-3mm
2s
-1
and 0.48±0.19x10
-3mm
2s
-1 respectively. Federau
et al.6 reported
f as 0.061±0.011 in white matter, was able to observe a correlation between
rCBV and f in gliomas, which we also found. Significant correlations of note include
CBF vs. fD*, v
b vs. rCBV and K
trans vs. K
2.
The significant correlation between f and K
trans has previously been
described in prostate
7
and is a potentially useful finding.
Conclusions
Promising correlations can be
seen between IVIM, and ASL, DCE and DSC parameters. The ability of IVIM to simultaneously
measure diffusion is an added benefit. Encouragingly, spatial registration of all
4 different methods yields acceptable agreement given technical differences.
Acknowledgements
This work was kindly funded by Yorkshire Cancer Research.References
1. Le Bihan D, Turner R. The Capillary
Network: A Link between IVIM and Classical Perfusion. Magnetic Resonance in Medicine 1992; 27(1): 171-8.
2. Jenkinson
M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM. FSL. NeuroImage 2012; 62(2):
782-90.
3. Boxerman
JL, Schmainda KM, Weisskoff RM. Relative cerebral blood volume maps corrected
for contrast agent extravasation significantly correlate with glioma tumor
grade, whereas uncorrected maps do not. American
Journal of Neuroradiology 2006; 27(4):
859-67.
4. Wu
WC, Chen YF, Tseng HM, Yang SC, My PC. Caveat of measuring perfusion indexes
using intravoxel incoherent motion magnetic resonance imaging in the human
brain. European Radiology 2015; 25(8): 2485-92.
5. Bisdas
S, Braun C, Skardelly M, et al. Correlative assessment of tumor
microcirculation using contrast-enhanced perfusion MRI and intravoxel
incoherent motion diffusion-weighted MRI: is there a link between them? NMR in Biomedicine 2014; 27(10): 1184-91.
6. Federau
C, Meuli R, O’Brien K, Maeder P, Hagmann P. Perfusion Measurement in Brain
Gliomas with Intravoxel Incoherent Motion MRI. American Journal of Neuroradiology 2013.
7. Pang YX,
Turkbey B, Bernardo M, et al. Intravoxel incoherent motion MR imaging for
prostate cancer: An evaluation of perfusion fraction and diffusion coefficient
derived from different b-value combinations. Magnetic Resonance in Medicine 2013; 69(2): 553-62.